PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
2B70.DE vs. QDVG.DE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


2B70.DEQDVG.DE
YTD Return14.75%14.68%
1Y Return31.27%20.30%
3Y Return (Ann)2.58%8.09%
5Y Return (Ann)8.13%11.72%
Sharpe Ratio1.871.89
Sortino Ratio2.762.75
Omega Ratio1.331.35
Calmar Ratio1.231.78
Martin Ratio8.579.13
Ulcer Index3.59%2.19%
Daily Std Dev16.66%10.63%
Max Drawdown-30.87%-26.77%
Current Drawdown-0.23%-1.52%

Correlation

-0.50.00.51.00.7

The correlation between 2B70.DE and QDVG.DE is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

2B70.DE vs. QDVG.DE - Performance Comparison

The year-to-date returns for both stocks are quite close, with 2B70.DE having a 14.75% return and QDVG.DE slightly lower at 14.68%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%JuneJulyAugustSeptemberOctoberNovember
12.88%
5.29%
2B70.DE
QDVG.DE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


2B70.DE vs. QDVG.DE - Expense Ratio Comparison

2B70.DE has a 0.35% expense ratio, which is higher than QDVG.DE's 0.15% expense ratio.


2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
Expense ratio chart for 2B70.DE: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%
Expense ratio chart for QDVG.DE: current value at 0.15% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.15%

Risk-Adjusted Performance

2B70.DE vs. QDVG.DE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


2B70.DE
Sharpe ratio
The chart of Sharpe ratio for 2B70.DE, currently valued at 1.71, compared to the broader market-2.000.002.004.006.001.71
Sortino ratio
The chart of Sortino ratio for 2B70.DE, currently valued at 2.61, compared to the broader market0.005.0010.002.61
Omega ratio
The chart of Omega ratio for 2B70.DE, currently valued at 1.30, compared to the broader market1.001.502.002.503.001.30
Calmar ratio
The chart of Calmar ratio for 2B70.DE, currently valued at 0.94, compared to the broader market0.005.0010.0015.000.94
Martin ratio
The chart of Martin ratio for 2B70.DE, currently valued at 7.71, compared to the broader market0.0020.0040.0060.0080.00100.007.71
QDVG.DE
Sharpe ratio
The chart of Sharpe ratio for QDVG.DE, currently valued at 1.81, compared to the broader market-2.000.002.004.006.001.81
Sortino ratio
The chart of Sortino ratio for QDVG.DE, currently valued at 2.56, compared to the broader market0.005.0010.002.56
Omega ratio
The chart of Omega ratio for QDVG.DE, currently valued at 1.31, compared to the broader market1.001.502.002.503.001.31
Calmar ratio
The chart of Calmar ratio for QDVG.DE, currently valued at 2.07, compared to the broader market0.005.0010.0015.002.07
Martin ratio
The chart of Martin ratio for QDVG.DE, currently valued at 7.52, compared to the broader market0.0020.0040.0060.0080.00100.007.52

2B70.DE vs. QDVG.DE - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 1.87, which is comparable to the QDVG.DE Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of 2B70.DE and QDVG.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.71
1.81
2B70.DE
QDVG.DE

Dividends

2B70.DE vs. QDVG.DE - Dividend Comparison

Neither 2B70.DE nor QDVG.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

2B70.DE vs. QDVG.DE - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, which is greater than QDVG.DE's maximum drawdown of -26.77%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and QDVG.DE. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-9.37%
-4.45%
2B70.DE
QDVG.DE

Volatility

2B70.DE vs. QDVG.DE - Volatility Comparison

iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 3.90% compared to iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) at 2.76%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than QDVG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%JuneJulyAugustSeptemberOctoberNovember
3.90%
2.76%
2B70.DE
QDVG.DE